These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3727763)

  • 1. Adrenoceptor blocking drugs and cold feet in intermittent claudication.
    Lepäntalo M; Lindström BL; Tötterman KJ
    Vasa; 1986; 15(2):135-7. PubMed ID: 3727763
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.
    Steiner JA; Cooper R; Gear JS; Ledingham JG
    Br J Clin Pharmacol; 1979 Apr; 7(4):401-3. PubMed ID: 375960
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmarketing comparison of labetalol and propranolol in hypertensive patients.
    Due DL; Giguere GC; Plachetka JR
    Clin Ther; 1986; 8(6):624-31. PubMed ID: 3791361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon as side effect of beta-blockers in hypertension.
    Marshall AJ; Roberts CJ; Barritt DW
    Br Med J; 1976 Jun; 1(6024):1498-9. PubMed ID: 6109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasospastic phenomena in patients treated with beta-adrenoceptor blocking agents.
    Eliasson K; Lins LE; Sundqvist K
    Acta Med Scand Suppl; 1979; 628():39-46. PubMed ID: 37701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol in the treatment of hypertension.
    Axford AT; Gilchrist L
    Br J Clin Pract; 1971 Jul; 25(7):326-8. PubMed ID: 5091610
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of propranolol and metoprolol on peripheral circulation in intermittent claudication].
    Diehm C; Mörl H; Schettler G
    Vasa; 1983; 12(1):59-63. PubMed ID: 6837129
    [No Abstract]   [Full Text] [Related]  

  • 9. Exacerbation of intermittent claudication by propranolol.
    Fogoros RN
    N Engl J Med; 1980 May; 302(19):1089. PubMed ID: 7366628
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raynaud's phenomenon caused by beta-receptor blocking drugs. Improvement after treatment with a combined alpha- and beta-blocker.
    Eliasson K; Danielson M; Hylander B; Lindblad LE
    Acta Med Scand; 1984; 215(4):333-9. PubMed ID: 6145298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

  • 14. Raynaud's phenomenon in hypertensive dialysis patients taking a sustained-release propranolol formulation.
    Poulter N; Gabriel R
    Curr Med Res Opin; 1979; 6(3):207-8. PubMed ID: 520027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cold challenge on finger skin temperature during long-term use of beta-adrenoceptor blocking drugs in hypertensive patients.
    Wollersheim H; Lenders J; Peters H; Thien T
    Int Angiol; 1987; 6(3):307-11. PubMed ID: 2896221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral vascular complications of beta-blocking agents].
    Guilmot JL; Perrotin D; Constans T; Pasticier A
    J Mal Vasc; 1984; 9(1):59-62. PubMed ID: 6142917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of hypertension with labetalol.
    Erichs M; Rothgardt NP; Andersson E
    Postgrad Med J; 1980; 56 Suppl 2():53-6. PubMed ID: 7433343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of labetolol and propranolol in patients with untreated hypertension].
    Wessel-Aas T; Walstad RA; Berg KJ
    Tidsskr Nor Laegeforen; 1981 Mar; 101(9-10):579-81. PubMed ID: 7221994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.